FDA advisors recommend that new Covid vaccines target an Omicron XBB variant this fall
The FDA advisory panel’s recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.
Stay updated with breaking news from John Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA advisory panel’s recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.
Portland businessman Everton 'Beachy Stout' McDonald, who is accused of killing his two wives in separate incidents, was today further remanded after his trial readiness hearing for one of the cases was postponed to July 31. The...
(This story has not been edited by THE WEEK and is auto-generated from a PTI
A panel of outside advisers to the US Food and Drug Administration will vote Thursday on the composition of updated Covid-19 vaccines that are expected to roll out in the fall, as the pandemic continues to recede from daily life but the coronavirus shows no signs of slowing its evolution.
The FDA has asked its advisers to discuss the specific strain to choose for the vaccine update but to vote only on whether the vaccine should target a single XBB strain.